Weekly Spotlight - 27.11.24

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

Latest News

Cure JM's New Grants Promise Hope for Juvenile Myositis

Cure JM celebrates its 20th year with four new research grants, supporting global projects on juvenile myositis (JM). Grantees focus on drug development, genetic signals, and muscle inflammation. Notable recipients include Baylor College, Duke Children's Hospital, NATA UK, and Nationwide Children's Hospital, each advancing understanding and treatment of JM. 

Living Fully with Dermatomyositis: A Journey of Resilience and Hope 

Jenna Radke's journey with dermatomyositis delayed her medical school plans but strengthened her resolve. Despite challenges, she remains passionate about medicine, valuing life beyond illness. Her story is one of resilience and balance, embracing joy and purpose while navigating the complexities of her condition. 

Argenx Progresses Efgartigimod SC for Myositis Treatment

Argenx is advancing the development of efgartigimod SC for idiopathic inflammatory myopathies, showing promise in Phase 2 trials. The ALKIVIA study continues with Phase 3, targeting three myositis subtypes. This innovative treatment offers hope for patients with limited options, aiming to improve their quality of life. 

Myositis Antibodies in Neurological Disorders: A Study of 727 Patients

The study examined myositis-specific and -associated antibodies in neurological disorders, revealing that these antibodies are often falsely positive in non-myositis diseases. Testing multiple antibodies isn't ideal for initial screening, but they can aid diagnosis when myositis is suspected. This offers hope for more accurate diagnoses.